Professionals discuss THCV’s association with energy and appetite suppression, plus whether or not it gets you high. Featuring Phylos Chief Scientific Officer, Alisha Holloway, PhD.

Hear from Phylos Chief Scientific Officer, Alisha Holloway, PhD as she discusses: • What solventless extraction is and why it's gaining popularity • The traits that make a cannabis plant a "good washer" • How Alisha’s team designed and conducted a washability study across hundreds of plant samples • How they identified genetic markers for good washers that hold up across diverse genetic backgrounds • How marker-assisted selection accelerates the breeding process

High Times Magazine recently published the article, “How Genomics Is Shaping the Future of Cannabis Genetics” by Angela Bacca. As part of the reporting, Phylos participated in a series of in-depth interviews with leading experts in cannabis genomics and genetics. Read the full Q&A with Phylos’ Chief Scientific Officer, Alisha Holloway, PhD, as she discusses Phylos’ groundbreaking genomic research and how it’s shaping the cannabis industry today.

Phylos genetics are launching into space in June 2026. Could the extreme conditions of space reveal new opportunities to learn more about the genome? As Cannabis Industry Journal notes, “It’s not as far out as you think.” Martian Grow is on a mission to find out.

Phylos’ genetics platform is designed to improve outcomes for all growers by combining uniform, reliable performance within cultivars with a broad and continuously evolving portfolio of genetically and phenotypically distinct hybrids. The expanded partnership with Organigram reflects a shared long-term view that cannabis production is moving toward modern agricultural systems built on predictable, data-driven genetics.

Organigram Global's announcement highlights the continued commitment of one of the world’s largest indoor cannabis producers to seed-based production powered by scientifically bred F1 hybrid genetics. At Phylos, we’re building a genetics platform designed to improve outcomes for all growers. Through continuous research and testing with partners like Organigram, Phylos has shown that modern F1 hybrid breeding can deliver consistent, high-performing genetics at scale.

Organigram had already made a strategic investment in U.S.-based Phylos Bioscience Inc., a leading in seed-based technology. The Company achieved 9% of cannabis harvest from seeds in Q4 Fiscal 2024 and 22% by the end of calendar 2024, contributing to a reduction in cultivation costs and increased cultivation capacity. "We made smart, strategic investments, including into seed-based technology and automation, which is increasing efficiency."

Phylos partner, ​​Organigram Global Inc, Canada’s #1 recreational cannabis company, is showing what’s possible when genetics and strategy align. In FY25, Organigram leveraged its partnership with Phylos to scale consistent, seed-based cultivation while maintaining national market leadership. The result: increased room turns, reduced labor costs, and a more efficient path to higher yield—highlighting how modern genetics can unlock real operational gains for commercial growers.

Cutting cultivation costs was a major theme at this year’s MJBizCon, and the latest Cannabis Industry Journal article highlights how modern seed genetics are leading the way. Phylos’ VP of Sales, Damon Hess, joined the “Mastering Genetics” panel at MJBizCon to discuss how stable, high-performing seeds can reduce costs, boost consistency, and deliver premium quality. The takeaway: when a plant yields more, your flower costs less. Now’s the time to tap into next-generation seeds.

Science is powering the next generation of cannabis genetics and redefining the economics of cannabis for growers across the industry. “We’re bringing growers better plants while maintaining the diversity of aromas and effects for consumers," Phylos’ Chief Scientific Officer, Alisha Holloway, PhD, says. By understanding the plant at a genetic level, Phylos helps producers grow more efficiently and deliver consistent, high-performing varieties that drive demand at the dispensary.

Tip #12, Grow From Seed: "Seed technology has come a long way. There are solid breeding companies producing true F1 hybrids—start there. We went with Phylos Bioscience. Growing from seed not only lowers our cost of labor from cloning, but a seed's tap root is much more vigorous, ensuring a more robust and healthy plant at the end of the life cycle. Not having to maintain mother stock is a plus for us."

Our Chief Scientific Officer, Alisha Holloway, PhD, describes Phylos’ dedication to unlocking the potential of cannabis by “creating new clonal cultivars that have higher levels of minor cannabinoids like THC-V or CBC”. Our work at Phylos is dedicated to unveiling everything the cannabis plant can do to produce naturally-occurring cannabinoids.

The legend, Jesce Horton names Phylos “One of the Best Genetics Companies in the Industry”. Jesce and Phylos have a long history of collaboration. He shares how his scientific approach to breeding alongside Phylos has allowed him to craft cultivars aligned with his brand.

By switching to seeds, cultivators can significantly reduce expenses related to labor, facility overhead, and integrated pest management (IPM).

F1 hybrid seeds are the cornerstone of modern agriculture, offering the least expensive and most reliable way to grow uniform plants with predictable traits.

Alisha Holloway is a data scientist and population geneticist with expertise in genomics and statistical analysis of big data. She held an assistant professor appointment at UC San Francisco School of Medicine, where she was the founding director of the Gladstone Institutes Bioinformatics Core Facility. She earned a PhD focused on molecular evolution at the University of Texas at Austin.

This legendary seed company leverages Phylos' advanced breeding to help you grow the best weed on the block.

Cultivation is part art, part science, and part luck, and the right tools help in all three areas. These products, designed for novices and seasoned professionals alike, are generating buzz for their effectiveness, ease of use, basis in science, and relative novelty.

“Outdoor growers who grow from [traditional] seed often struggle with uniformity issues, [hermaphroditism], basic seed quality, and germination rates,” according to Phylos Bioscience Chief Science Officer Alisha Holloway. F1 hybrid seeds typically solve all those problems, she said.

Phylos’s new Production-Ready Seeds produce superior results without clones’ drawbacks.

Step aside clones! Phylos’ Elite Production-Ready Seeds offer uniform, potent and aromatic flower from seed, revolutionizing cannabis growth for a more efficient and scalable future.

Beyond the well-known tetrahydrocannabinol (THC), the psychoactive component responsible for the “high,” lies a hidden world of rare cannabinoids with the potential to revolutionize recreational, health, and wellness markets.

Phylos Bioscience, a provider of genetics and rare cannabinoids, stands out for its advanced DNA-marker-assisted breeding technology.

Organigram Holdings Inc., a leading licensed producer of cannabis, announced today that it has completed an early partial funding of its final third tranche investment into Phylos Bioscience Inc.

Phylos and marijuana research firm People Science announced the results of the study they conducted, which demonstrated that a THCV product “significantly increased energy, activity, motivation and well-being compared to placebo.”

As the cannabis industry continues to evolve, the focus on rare cannabinoids like THCV, backed by solid scientific research, is set to transform the market, offering consumers natural, effective alternatives for enhancing their well-being.

Whitney Conroy as Chief Commercial Officer will be responsible for all revenue-generating activities of the company and will report to Phylos' Chief Executive Officer Ralph Risch.

In a very tough year for Oregon venture capital, Phylos' fundraising was the second largest in the state in 2023.

Phylos Production-Ready Seeds can lower the cost of cultivation. Plus Cannabis 3.0 is heading towards effects-based cannabis.

Organigram to advance the conversion of its grow rooms with custom designed, F1 Hybrid seeds

Cannabis hunters traveled across the world and risked their lives looking for THCV, yet no one seemed to be able to find a consistent supply of it. Now, that’s all changing.

By harnessing the potential of production-ready seeds, Streamline Farms achieves scalability, profitability with modern seed genetics.

Canadian producer Organigram Holdings is investing as much as $8 million in Portland, Oregon-based cannabis genetics and seeds company Phylos Bioscience. Under the deal, Organigram will shift to producing cannabis from seed and create new products containing the minor cannabinoid THCV.

Previously shunned by some cultivators, modern plant breeding and data science is bringing seed-grown cannabis up to par with clonal varieties.

Phylos seeds are ready to pop in soil just like any packet of tomato seeds you might buy. They've done the pheno hunting and data analysis for growers wanting to eliminate the process to save time and get to market faster.

Phylos is providing a long-awaited solution for commercial growers looking for uniformity, input reduction, and risk mitigation for large-scale cannabis and hemp production — highly-optimized production-ready F1 hybrid seed.

A new study of cultivation techniques by Phylos Bioscience and Progressive Plant Research shows that using larger pots and a high-density planting arrangement will produce the highest biomass and extract yield. However, large pots and lower density will produce a higher percentage of Grade A flower per plant, leading to a higher price point.

Regulatory hurdles, research restrictions, and limited banking options have plagued the cannabis space for years and although forward progression is happening relatively quickly, a new concern has recently become the central topic of discussion for many in the industry — sustainability.

As states continue to loosen their regulatory grip and allow cannabis trade, environmentalists, farmers, and researchers have brought to light the concern of commercial cannabis’ impact on the environment.

Phylos, PPR researchers conduct experiments to determine optimal plant density strategies for smaller grow operations.

Phylos, alongside its research and cultivation partner Progressive Plant Research (PPR), have announced the results of their day-neutral cannabis density trial.

The Portland cannabis genetics company, founded in 2014, soldiered on after losing its cool-startup luster in a 2019 PR crackup, and on Tuesday announced a $7.6 million funding round.

It all begins with the seeds - Phylos believes quality control starts in breeding and continues through seed production. The final hemp & cannabis product means buyers can trust the quality and consistency of the strains they are purchasing. Let’s listen to the entire interview with Ralph who discusses this in more detail, and you'll learn what autoflower means to a successful grow operation.

Even in a world upended by a deadly pandemic and harsh economic realities, cannabis companies proved people are the heart of their business.

In partnership with its dedicated research and cultivation partner Progressive Plant Research, Phylos is projecting a reduction of total energy use by 36% due to the significant improvements and automation made to the facility since the conversion to a cannabis and hemp greenhouse cultivation operation.

A hemp crop science company has aligned with the National Black Farmers Association and Oregon State University to provide 1 million hempseeds to Black and Indigenous growers and farmers of color without capital investment. The effort, led by Portland, Oregon-based Phylos Bioscience, aims to provide opportunity for communities that are disproportionately affected by the war on drugs.

Phylos debuts on GeekWire 200, a ranked index of Pacific Northwest startups.

Phylos's Alisha Holloway, PhD is celebrated as one of The Cannabis Scientist's 20 most influential people in cannabis analytics.

Companies like Phylos are looking to partner with hemp distributors across the nation to help bring transparency to the hemp industry.

Phylos, a Portland-based hemp and cannabis science company, has brought its first hemp seed, called AutoCBD, to market.

Episode 56: On this week’s podcast we talk to Dr. Mowgli Holmes, co-founder and CEO of Phylos, a plant science company that is trying to revolutionize the hemp industry through data, technology and expertise.

If you're looking for a high-THC experience from cannabis flower, these 10 strains historically test high in the cannabinoid.

The famed cannabis breeder Subcool shares his story of surviving and thriving.

Science and technology are about to revolutionize cannabis, but longtime players fear they’ll get snuffed out in the process.

Cannabis Aficionado spoke to CEO Mowgli Holmes to learn more about their approach to large-scale agriculture, plant patents and IP rights, and the future of cannabis.

A hemp seed producer and a genetics firm fight to maintain their leadership positions as the cannabis regulatory terrain opens up.

SugarBud Craft Growers Corp will be partnering with Phylos Bioscience to catalog their diverse collection of cannabis varieties.

Scientists and growers are working to find order in tangled strain genetics, but ancestry claims are difficult to substantiate.

Counsel at Steep Hill Labs, Phylos Bioscience, Medicinal Genomics and the Open Cannabis Project explain how cannabinoid innovation could be blocked by overly broad or weak patents at the USPTO, and what the industry is doing to develop, collect and record prior art

Marijuana companies are hiring scientists to develop a plant that will produce consistent, reliable highs.

Turns out, there's lots of money to be made by servicing the companies that are growing and selling legal weed.

Ralph Risch, COO, of Phylos is an experienced entrepreneur and business leader who has founded and successfully exited multiple companies in the high tech industry. He has a BS in Engineering and Computer Science from the University of Colorado.

The weed industry in the Beaver State is focused on clean pot, educated customers and really cute stores.

Co-Founder and CEO Mowgli Holmes discusses the company’s genetic certification process, the benefits it provides cultivators and the company’s Phylos Galaxy, a snapshot of today’s cannabis genetics.

Which Is Why Phylos Is Mapping Your Weed’s Genetics

With only commercial support, testing labs in weed-friendly states are finally exploring the genes of ganja.

Van Patten is one of a growing number of cannabis cultivators who would like to see breeders approach marijuana cultivation in a more scientific way instead of haphazardly cross-breeding varieties to see what they can get.

Industry players swear pot’s many chemicals work in concert, but most scientists hear a THC solo

Genomic Mapping: The New Cannabis Luxury Experience

Using weed's DNA, Mowgli Holmes has created the world's largest genomic database of marijuana

Will we really be smoking Dr. Hunter S. Thompson’s stash?

To the cannabis industry, a patent granted last August was either doomsday or the dawn of a new era, depending on who you asked.

The genetic landscape may be about to change dramatically and affect growers everywhere.

Mowgli Holmes is the co-founder and Chief Science Officer of Phylos Bioscience, a cannabis genomics firm whose mission includes telling the evolutionary story of the cannabis plant.

Most people come face-to-face with marijuana strains in dispensaries, on a forum or from a dealer, but what if they could scroll through about 1,000 strains and their "statistical relationships" through a three-dimensional graphic?

On Wednesday, Phylos Bioscience, an Oregon biotechnology start-up, will begin offering an online interactive guide that visually portrays the genetic relationships of almost 1,000 types of cannabis, otherwise known as marijuana.

Because he's a scientist, not a back-slapping venture capitalist, Mowgli Holmes loathes using the term networking to describe even the portion of his job that entails shaking hands in the cannabis industry.

DNA sequencing may also go a long way in helping to remove some of the imposter plants from the general cannabis gene pool as clones become ‘known’ and ‘tagged’ through that registry.

Smoke Reports has always been very appreciative of all of the different organizations publishing positive cannabis information and research. Phylos Bioscience, based out of Portland, Oregon, is certainly one such company that deserves recognition for their dynamic research of cannabis genetics.

Marijuana research has been impeded for years due to its illegal status nationally. So now that states are decriminalizing the drug and opening medical marijuana programs, where do they turn for scientific guidance?

Our seedlings have been gender tested and the results are in.

Katie Wuestenberg dons protective while spraying the marijuana plants with a vitamin B supplement at Chalice Farms in West Linn.

Every morning, Josh Chase makes his way from Goetz House, a yellow-and-white cottage in the middle of nowhere Washington, past a makeshift 8-foot “security fence” built from square-cut pieces of lumber and black plastic tarp, down to the greenhouses.

Weed's been with us since the Ancient Steppes. Portland's Phylos Bioscience will revolutionize what we know about it.

Exploring pot's family tree

Before Lemon Haze and Super Skunk, it was mostly just good and bad weed.